ALFA Finder| Revenue growth | 20% YoY growth on proforma basis. |
|---|---|
| Margins | Improving; driven by operating leverage and better clinical case mix. |
| Demand visibility | Strong; 2 million patients treated in Q1, up 13% YoY. |
| Management confidence | High; citing historic milestone and strong shareholder support. |
Growth
Revenue rose 20% YoY to INR 2,597 Cr; EBITDA grew 30% to INR 576 Cr. EBITDA margin expanded 170 bps to 22.2%.
Outlook
Targeting 24-25% EBITDA margins in 2-3 years. Roadmap to add 4,170 beds, taking total capacity over 15,000.
Risks
One-time merger costs of INR 114 Cr; integration of large hospital networks; competitive intensity in metro markets like Bengaluru.
Last quarter's promises, checked
Delivered
- Guided merger completion within Q1 FY27 → delivered merger effective (BEAT)
- Targeted Whitefield Block D launch April 2026 → delivered 159-bed launch (BEAT)
- Guided 75-bed Ramesh Ongole launch April 2026 → delivered operationalization (BEAT)
Partly delivered
- Guided 2,500 bed addition over coming years → delivered 4,170 bed roadmap (PARTIAL - roadmap expanded)
Investor Presentation filed with BSE, NSE: ASTERDM. Summary written with AI assistance from the document.
Aster DM Quality Care Ltd: key numbers
- Share price
- ₹724.20
- Market cap
- ₹63,127 Cr
- Revenue (annual)
- ₹4,643 Cr
- Net profit (annual)
- ₹388.1 Cr
- P/E (TTM)
- 134.1×Sector 54.5×
- Promoter holding
- 53.79%+13.40% QoQ
- FII holding
- 12.26%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aster DM Quality Care Ltd
All →Aster DM Quality Care Adverse Business Impact
Aster DM Quality Care terminated its O&M and Medical Services agreements with DM Education and Research Foundation, ceasing related hospital operations. The Aster Wayanad hospital contributed 1.20% of turnover; no consideration was received.
Aster DM Quality Care Acquisition Worth ₹102.5 Cr
Aster DM will acquire Sri Sainatha Hospitals by converting a Rs 102.46 Crore loan into equity. The related-party deal completes within three months.
- Value
- ₹102.5 Cr
- Execution
- Within 3 months
Aster DM Quality Care Capital Structure Change
Aster DM approved converting a Rs 102.46 Crore subsidiary loan into equity shares. It also approved terminating DMERF operations and medical services agreements.
- Value
- ₹102.5 Cr
- Execution
- Within 3 months
Aster DM Quality Care Results Update
Aster DM Quality Care released a press release on its Q2 FY27 unaudited results, reporting revenue up 19% to Rs 2,829 crore. Normalised PAT rose 34% to Rs 281 crore.
Aster DM Quality Care Investor Presentation: Key Takeaways
Q2 FY27 revenue INR 2,829 Cr (+19% YoY), Op EBITDA INR 678 Cr (+25%), margin 24.0% (+111 bps), normalised PAT INR 281 Cr (+34%). Post-merger synergies and bed expansion to 15,070.
Aster DM Quality Care Q2 FY27 Results: Net Profit ₹322.4 Cr, Up 165.8% YoY
Aster DM Quality Care Ltd reported revenue from operations of ₹2,829 Cr (+136.3% YoY) and net profit of ₹322.4 Cr (+165.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹322.4 Cr · +165.8% YoY